LeAnne Denney is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between Aug 2011 and Jun 2013: iVantage Health Analytics, Inc. (Portsmouth, NH — other health care — 2011–2013; $10.9M reported sold to 15 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Rowland J. Morrow (2 shared filings), Suzanne Colby (2 shared filings), Thomas Day (2 shared filings), W. Hudson Connery, Jr. (2 shared filings), Ayman Hamdan (1 shared filing) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around LeAnne. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for LeAnne Denney and found 2 differences: Form D filed 19 days after the first sale; LeAnne Denney's role changed at iVantage Health Analytics, Inc.: executive officer, director → executive officer.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.